The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mahony Susan since 2012.
This trader's CIK number is 1463321.
At the time of last reporting, Mahony Susan was the Director of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP).
Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HZNP | 0 | $0 | 0 | $0 | 3,913 | $0 |
| 2022 | HZNP | 0 | $0 | 0 | $0 | 4,223 | $0 |
| 2021 | HZNP | 0 | $0 | 0 | $0 | 11,098 | $0 |
| 2020 | HZNP | 0 | $0 | 0 | $0 | 12,036 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | LLY | 0 | $0 | 22,544 | $1,805,633 | 21,326 | $0 |
| 2017 | LLY | 0 | $0 | 36,585 | $3,152,895 | 9,732 | $0 |
| 2016 | LLY | 0 | $0 | 20,242 | $1,470,884 | 9,843 | $0 |
| 2015 | LLY | 0 | $0 | 25,000 | $2,124,000 | 21,627 | $507,642 |
| 2014 | LLY | 0 | $0 | 32,065 | $2,047,714 | 24,868 | $474,193 |
| 2013 | LLY | 0 | $0 | 13,500 | $748,555 | 26,999 | $0 |
| 2012 | LLY | 0 | $0 | 10,000 | $504,500 | 0 | $0 |
1. Horizon Therapeutics Public Ltd Co (HZNP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-28 | HZNP | Option Ex | 3,913 | .00 | 0 |
| 2022-04-29 | HZNP | Option Ex | 4,223 | .00 | 0 |
| 2021-04-30 | HZNP | Option Ex | 11,098 | .00 | 0 |
| 2020-05-02 | HZNP | Option Ex | 12,036 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-04-13 | LLY | Sale | 5,165 | 80.14 | 413,923 |
| 2018-04-16 | LLY | Sale | 17,379 | 80.08 | 1,391,710 |
| 2018-02-01 | LLY | Option Ex | 21,326 | .00 | 0 |
| 2017-12-04 | LLY | Sale | 36,585 | 86.18 | 3,152,895 |
| 2017-02-01 | LLY | Option Ex | 9,732 | .00 | 0 |
| 2016-12-16 | LLY | Sale | 20,242 | 72.67 | 1,470,884 |
| 2016-02-01 | LLY | Option Ex | 9,843 | .00 | 0 |
| 2015-07-28 | LLY | Sale | 25,000 | 84.96 | 2,124,000 |
| 2015-02-11 | LLY | Option Ex | 9,036 | 56.18 | 507,642 |
| 2015-02-01 | LLY | Option Ex | 12,591 | .00 | 0 |
| 2014-08-13 | LLY | Option Ex | 8,521 | 55.65 | 474,193 |
| 2014-07-28 | LLY | Option Ex | 2,240 | .00 | 0 |
| 2014-07-28 | LLY | Sale | 2,065 | 63.30 | 130,714 |
| 2014-07-25 | LLY | Sale | 30,000 | 63.90 | 1,917,000 |
| 2014-02-01 | LLY | Option Ex | 14,107 | .00 | 0 |
| 2013-11-04 | LLY | Option Ex | 4,056 | .00 | 0 |
| 2013-04-29 | LLY | Sale | 3,500 | 56.33 | 197,155 |
| 2013-03-26 | LLY | Sale | 5,000 | 56.00 | 280,000 |
| 2013-02-01 | LLY | Option Ex | 22,943 | .00 | 0 |
| 2013-02-01 | LLY | Sale | 5,000 | 54.28 | 271,400 |
| 2012-10-24 | LLY | Sale | 10,000 | 50.45 | 504,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mahony Susan (Director of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.